DNA Probes–Based Diagnostics Market is Set to Garner Staggering Revenues by 2024

Global DNA Probes-based Diagnostics Market: Overview

The global DNA probes-based diagnostics market is expected to witness robust growth in the forthcoming years. The human genome is estimated to contain about 100,000 genes and potentially, an irregularity in any of these can result in a hereditary trait or disease. DNA probes-based technology is associated with the examination of the chemical structure of DNA by undoing the presence of anomalous gene sequence on the DNA strand. It is extensively implemented in diagnostics and also in other fields such as molecular biology, microfabrication, data handling, instrumentation development, surface chemistry, and biological sample preparation. Public awareness of these techniques for prenatal diagnosis and carrier detection is rising rapidly and may result in a significant increase in the demand for such services.

Read Report Overview: https://www.transparencymarketresearch.com/dna-probes-based-diagnostics.html

This market intelligence report presents a detailed description of the dynamics impacting the growth of the global DNA probes-based diagnostics market. It analyzes various application and geographical segments of the market in terms of both revenue and volume. Primary and secondary research resources have come into play for deriving the market data and analytics. The report also profiles prominent players in the market along with their business strategies, latest developments, cost and revenue structures, and contact information. There is a separate section for recommendations, which are lucrative for both existing and new players in the market for forming their important business strategies. This report, hence, provides a 360-degree view of the global DNA probes-based diagnostics market.

Global DNA Probes-based Diagnostics Market: Drivers and Restraints

The global DNA probes-based diagnostics market is primarily driven by the increasing prominence of the technology in diagnosing infectious diseases including vaginitis. Over the past few years, the investments in pharmaceuticals and pharmacogenomics research and development have increased substantially. This has paved way for advancements in DNA array technologies, leading to the launch of new equipment facilitating execution of tests with higher speed, accuracy, and reliability and is, therefore, influencing the growth of the market positively. Moreover, the advent of novel methods for high-volume testing is augmenting the market. Growing geriatric population and rising disposable income are some of the other factors fuelling the global DNA probes-based diagnostics market.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1080

On the other hand, there are certain limitations associated with this technology that are hampering the growth of the global market. These limitations include genetic heterogeneity, recombination between the marker and disease alleles, and incorrect pedigree data or non-paternity leading to erroneous diagnosis. However, the increasing penetration of automation in diagnosis tests is likely to create immense growth opportunities for the global DNA probes-based diagnostics market.

Global DNA Probes-based Diagnostics Market: Segmentation

On the basis of geography, the global DNA probes-based diagnostics market can be categorized into Asia Pacific, North America, Europe, and Rest of the World. North America is anticipated to command a large share throughout the forecast period, with the U.S. being the major contributor. The rapid advancements in technology in this region are enabling the complex genetic tests to shift from research laboratories to clinical and medical laboratories. Europe is also poised to experience steady growth.

The Asia Pacific market for DNA probes-based diagnostics is estimated to expand at a noteworthy CAGR during the same period owing to the improving healthcare infrastructure and increasing government funding for medical research. Moreover, factors such as the rapidly growing population, and rising healthcare expenditure are working in favor of the growth of the region.

Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1080

The key application areas of the market include genetic predispositions, forensic testing, infectious diseases, molecular human leukocyte antigen (HLA), cancer testing, and others. The demand for DNA probes-based technology for diagnosing infectious disorders is likely to remain high throughout the forecast period. It is also finding increasing application in genetic predispositions.

Companies Mentioned in the Report:

The majority of the companies operating in the global DNA probes-based diagnostics market are increasingly focusing on extensive research and development in order to sustain the competition. Some of the key players are Abbott Laboratories, Affymetrix Inc, Beckman Coulter, Becton Dickinson & Company, Biogenex Laboratories Inc., bioMérieux, Genzyme Corporation, Luminex Molecular Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., QIAGEN, and MP Biomedicals, Gen-Probe Inc.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Transparency Market Research (Tmr) is a U.S.-based provider of syndicated research, customized research, and consulting services.